Target intelligence / Profile preview

Donor splice site (5' splice site (or 5ʹss))

Target
5' splice site (or 5ʹss)
Molecular classification
Other
01

Overview

The donor splice site, also known as the 5' splice site or 5ʹss, is a conserved nucleotide sequence at the exon-intron junction in pre-mRNA, typically beginning with the dinucleotide GT (GU in RNA), that marks the 5' end of an intron for recognition by the spliceosome.[1][3][5] During RNA splicing, U1 snRNP first binds this site to initiate spliceosome assembly, followed by recruitment of other components like U2 snRNP to the branch point and acceptor site, enabling two transesterification reactions that excise the intron and ligates exons.[1][3] Splicing kinetics at the donor site vary by sequence strength, intron length, and nucleotide composition, with optimal consensus sequences promoting faster cleavage and higher efficiency.[1][2] Mutations disrupting this site, such as changes to the GT dinucleotide, frequently cause aberrant splicing, leading to intron retention, exon skipping, or inclusion of intronic sequences, which produce dysfunctional proteins.[2][7][12] These variants are implicated in various genetic disorders and contribute to disease pathology, including cancer, by altering gene expression and protein function, though they are not directly targeted by approved therapeutics.[2][7][12]

Other names
5' splice site5ʹssdonor siteGT site5'-splice sitesplice donor site
02

Biological functions

RNA splicingpre-mRNA processingintron removalexon ligation
03

Disease associations

Genetic disease (via mutations)Cancer (via splice site variants)

Beyond the preview

Go deeper on Donor splice site (5' splice site (or 5ʹss)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Donor splice site (5' splice site (or 5ʹss)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call